How much is VeraDermics worth in 2026?

VeraDermics has a current valuation of $290.0M based on their Later Stage VC round and secondary market data.

How much funding has VeraDermics raised?

VeraDermics has raised $262.3M in total funding across 1 funding rounds.

VeraDermics

Drug DiscoveryWebsite

VeraDermics valuation and funding history | Last updated: October 10, 2025 | 1 funding rounds

Current Valuation

$290.0M

As of October 10, 2025

Total Funding Raised

$262.3M

Across 1 round

Last Round

Later Stage VC

$150.0M

Last Funding

Oct 2025

Funding date

Capital Efficiency

1.11x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 10, 2025	Later Stage VC (Series C)	$150.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

VeraDermics is currently valued at $290.0M as of October 10, 2025. The company has raised a total of $262.3M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 1.11x, VeraDermics has achieved a valuation that is 1.11 times the total capital raised.

Track VeraDermics Valuation Updates

Get notified when VeraDermics raises new funding or valuation changes

Explore More Data

Detailed analysis for VeraDermics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock VeraDermics's valuation history, funding rounds, and growth metrics.

No credit card required

What is VeraDermics Worth in 2026?

VeraDermics is a leading private company in the Drug Discovery sector. Track VeraDermics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How VeraDermics Valuation is Determined

Private company valuations like VeraDermics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.